What is DGZ's health score?

DEUTSCHE BANK AKTIENGESELLSCHAFT (DGZ) has a TradeApes health score of 41 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is DGZ's estimated fair value?

Based on our 5-year discounted cash flow model, DEUTSCHE BANK AKTIENGESELLSCHAFT's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is DGZ undervalued or overvalued?

Our model currently rates DGZ as Fair Value. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for DGZ... Refresh in a moment for the full analysis.

DEUTSCHE BANK AKTIENGESELLSCHAFT (DGZ)

Financials Fair Value High weak

Updated: 2026-04-21

TradeApes Score

reduce

Financial Strength

20 Stressed

Operating Trend

50 Mixed

Relative Value

30 Weak

Capital Allocation

50 Mixed

Risk

80 Strong

Key Findings

+ Strong FCF growth — free cash flow up more than 20% year over year

Unlock Full Report →

− Weak interest coverage — earnings barely cover debt service

Unlock Full Report →

2 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.